Labcorp Holdings Inc.

LH Healthcare Diagnostics & Research

Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024.

Revenue
+6.92%
EPS
+3.18%
Free cash flow
+44.7%
Total debt
+3.21%

Quarter to September 2026, against a year earlier

366.77 3.47 +0.96%
Market cap
$29.5B
P/E
29.5×
Fwd P/E
26.7×
Dividend yield
0.79%
F-score
8/9
Altman Z
3.02
Beneish M
−2.55
Dividend safety
74/100

Labcorp Holdings Inc. 10-Q filed Aug 1, 2025

Fiscal Q2 2025 · Period ended Jun 30, 2025 · Filed · accepted 1:25 PM ET · Document on sec.gov · Filing index

What changed

Part II, Item 1A, Risk Factors, against the 10-Q filed Apr 29, 2025: no material changes, the filing says